The Licensed Pharmacist column has compiled "Several Policies on Medicine in 2017." Everyone, please be prepared.
On January 24, the approval of online pharmacies was fully liberalized, and the spring of pharmaceutical e-commerce is really here!
On January 21, the State Council announced the "third batch of cancellation of 39 items" In the "Catalogue of Administrative Licensing Matters Implemented in the Centrally Designated Local Areas", the approval of B and C certificates for Internet drug trading qualifications has been cancelled. This is an unexpected gain on the eve of the Spring Festival in 2017.
After the news came out, the circle of friends of practitioners in the pharmaceutical industry have been flooded with this news in the past few days. The group cheering the loudest is the pharmaceutical e-commerce practitioners. It is generally believed that the policy is taking care of pharmaceutical e-commerce. The business model, approval and filing changes, streamlining administration and delegating power will benefit retail chain enterprises. However, some people in the industry hold a calm attitude, believing that this time is just a manifestation of the national policy of streamlining administration and delegating power, and it is not worth being overly optimistic until the corresponding supporting details are introduced.
On January 25, major reform policies for the entire chain in the pharmaceutical field will be released soon
On January 25, the State Council Information Office held a briefing. Director of the State Council Medical Reform Office and Deputy Director of the National Health and Family Planning Commission Director Wang Hesheng and Deputy Director of the Food and Drug Administration Wu Zhen introduced the relevant situation of "Several Opinions" and answered reporters' questions. In addition, responsible comrades from relevant departments and bureaus of the Ministry of Industry and Information Technology, the Ministry of Human Resources and Social Security, the Ministry of Commerce, and the Bureau of Traditional Chinese Medicine also attended the meeting and answered relevant questions.
According to reports, the "Several Opinions" pointed out that the key to improving the quality and efficacy of drugs in the production process. The first is to strictly review and approve drugs for marketing, optimize the review and approval procedures, and promote information disclosure. The second is to accelerate the consistency evaluation of the quality and efficacy of generic drugs on the market and provide policy support to drugs that pass the consistency evaluation. The third is to advance the pilot program of the marketing authorization holder system in an orderly manner and encourage the research and development of new drugs. The fourth is to strengthen the quality and safety supervision of drug production and severely crack down on illegal and criminal activities involving the production and sale of counterfeit and inferior drugs. The fifth is to increase the structural adjustment of the pharmaceutical industry and promote the exit of backward enterprises. Sixth, improve the monitoring, early warning and hierarchical response mechanism for shortages of drugs and low-priced drugs to ensure the effective supply of drugs.
"Several Opinions" requires that the circulation order should be rectified and the circulation system should be reformed and improved. The first is to promote the transformation and upgrading of drug distribution enterprises and improve the urban and rural drug distribution network. The second is to implement the "two-invoice system" for drug purchases and sales, and strive to launch it nationwide by 2018. The third is to implement the drug classification procurement policy and reduce the falsely high prices of drugs. The fourth is to strengthen the management of drug purchase and sales contracts, and those who violate the contract will be subject to corresponding penalties. The fifth is to rectify outstanding problems in the field of drug circulation, severely punish illegal enterprises, medical institutions and relevant responsible personnel in accordance with the law, and record bad credit records. Sixth, establish a traceability mechanism for drug price information to promote price information transparency. Seventh, actively leverage the advantages and role of “Internet drug circulation” to facilitate the public’s use of medicines.
"Several Opinions" emphasizes that the profit-driven mechanism must be reformed and adjusted during use, so that drugs can return to their original purpose of treating diseases. First, public hospitals should give priority to the use of national essential drugs, strengthen supervision of drug use, and promote rational use of drugs. The second is to further eliminate the mechanism of supplementing medical treatment with drugs and strictly control the unreasonable increase in medical expenses. The third is to strengthen the role of medical insurance in regulating behavior and controlling costs, vigorously promote the reform of medical insurance payment methods, and encourage medical institutions to actively standardize medical behaviors. The fourth is to actively play the role of pharmacists in the rational use of drugs.
On January 26, the national retail pharmacy market size in 2016 was 337.7 billion, with a growth rate of 9.2.
Recently, the National Bureau of Statistics released my country’s 2016 economic data: domestic production in 2016 The total value (GDP) was 74.4 trillion yuan, an increase of 6.7% compared with 2015. At the same time, as domestic professional pharmaceutical data research institutions, Zhongkang CMH and Zhongkang Research Institute have, as always, timely and efficiently released blockbuster data on my country's pharmaceutical retail industry in 2016. For the first time, it has a network of 440,000 terminal stores, 300 Provide decision-making support to 10,000 pharmaceutical retail industry practitioners who directly face front-line health needs.
On January 27, my country has officially launched the legislation of the Pharmacist Law
On January 27, CCTV Chaowen Tianxia reported that the National People's Congress and the National Health and Family Planning Commission are preparing for the "Pharmacist Law" in the legislative process. Recently, relevant persons in charge of the Medical Reform Office of the State Council and the National Health and Family Planning Commission stated. At present, the National People's Congress has included the Pharmacist Law in the legislative plan, and is working with relevant departments to carry out relevant research and preliminary research preparations. In accordance with relevant requirements, it will fully listen to opinions and suggestions from all parties and accelerate the legislative process of the Pharmacist Law.
On February 4, the cause of traditional Chinese medicine is ushering in new opportunities and entering a new period of development
Recently, my country’s first national law formulated for the revitalization of traditional Chinese medicine - " The "Traditional Chinese Medicine Law of the People's Republic of China" (hereinafter referred to as the "Traditional Chinese Medicine Law") was officially promulgated and will come into effect on July 1, 2017. The promulgation of the "Traditional Chinese Medicine Law" has further opened up the door for the traditional Chinese medicine industry in terms of qualifications, access and management regulations, making the development of traditional Chinese medicine more law-based. The traditional Chinese medicine industry is ushering in new opportunities and entering a new era. development period.
The implementation of the "Traditional Chinese Medicine Law" has been interpreted as a powerful legal aid and support for promoting the healthy development of traditional Chinese medicine. Relevant information shows that in 2008, the Standing Committee of the Eleventh National People's Congress included the law in the legislative plan; in 2009, the "Opinions of the State Council on Deepening the Reform of the Medical and Health System issued by the Central Committee of the Communist Party of China" clearly required the acceleration of traditional Chinese medicine legislation; in 2011 In December, the former Ministry of Health submitted the draft of the "Traditional Chinese Medicine Law" to the State Council for review; in December 2015, the State Council submitted the draft of the Traditional Chinese Medicine Law to the Standing Committee of the National People's Congress for review; in December 2015 and August and December 2016 In August, the Standing Committee of the National People's Congress passed the "Traditional Chinese Medicine Law" after three deliberations.
As we all know, traditional Chinese medicine is known as "the key to unlocking the treasure house of Chinese civilization." With the changes in people's health concepts and the continuous innovation of medical models in recent years, traditional Chinese medicine has gradually played an important role in domestic health and health work. play a more important role. However, whether it is a change in concepts or an increase in demand, it is only a boost to the development of traditional Chinese medicine. The final implementation of the "TCM Law" will make enterprises and practitioners engaged in the traditional Chinese medicine industry more orderly in production, operation and daily work. There are laws to follow.
The "Several Opinions on Further Reforming and Improving Drug Production, Distribution and Use Policies" (hereinafter referred to as "Several Opinions") drafted by the Medical Reform Office of the State Council and the Food and Drug Administration in conjunction with relevant departments have been previously approved by the entire State Council Medical Reform Leading Group. The meeting and the meeting of the Central Leading Group for Comprehensively Deepening Reforms reviewed and approved it, and the General Office of the State Council will issue it for implementation in the near future.
The Licensed Pharmacist Examination Column recommends for you: